Haleos Labs Limited (BOM:540679)
India flag India · Delayed Price · Currency is INR
1,130.10
+38.60 (3.54%)
At close: Aug 29, 2025

Haleos Labs Company Description

Haleos Labs Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.

The company offers APIs in various therapeutic areas, such as anti ulcer, erectile dysfunction, anti gout, anesthesia, anti infective, anti obesity, antifungal, anti convulsant, anti emetic, ophthalmic, anti worm, and antiemetic.

It is also developing APIs in the areas of anti depressant, anti psychotic, anti hypertension, veterinary, antiviral, and anticoagulant.

In addition, the company offers intermediates in the anti ulcer, anti migraine, anti hypertension, erectile dysfunction, anti cancer, antifungal, anti obesity, anti emetic, anti depressant, anti worm, anti gout, anti infective, anti convulsant, antiviral, and anesthesia.

It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025.

Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.

Haleos Labs Limited
CountryIndia
Founded1990
IndustryPharmaceutical Preparations
Employees574
CEOTalluri Veera Venkata Murthy

Contact Details

Address:
Plot No. 19-III
Hyderabad, 500 096
India
Phone91 40 6628 8888
Websitesmslife.in

Stock Details

Ticker Symbol540679
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2834

Key Executives

NamePosition
Talluri Veera Venkata MurthyChief Executive Officer
Nadella PrasadChief Financial Officer
Lakshminarayana SomisettyChief Operating Officer